Nehal E. Elsadek

828 total citations · 1 hit paper
17 papers, 614 citations indexed

About

Nehal E. Elsadek is a scholar working on Molecular Biology, Immunology and Biomaterials. According to data from OpenAlex, Nehal E. Elsadek has authored 17 papers receiving a total of 614 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Immunology and 4 papers in Biomaterials. Recurrent topics in Nehal E. Elsadek's work include RNA Interference and Gene Delivery (7 papers), Immunotherapy and Immune Responses (5 papers) and Nanoparticle-Based Drug Delivery (3 papers). Nehal E. Elsadek is often cited by papers focused on RNA Interference and Gene Delivery (7 papers), Immunotherapy and Immune Responses (5 papers) and Nanoparticle-Based Drug Delivery (3 papers). Nehal E. Elsadek collaborates with scholars based in Egypt, Japan and Saudi Arabia. Nehal E. Elsadek's co-authors include Tatsuhiro Ishida, Taro Shimizu, Sherif E. Emam, Yu Ishima, Hidenori Ando, Hatem A. Sarhan, Amal K. Hussein, Eslam Ramadan, Omar H. El-Garhy and Mohamed Yousif Ibrahim and has published in prestigious journals such as Journal of Controlled Release, International Journal of Pharmaceutics and Journal of Pharmaceutical Sciences.

In The Last Decade

Nehal E. Elsadek

16 papers receiving 603 citations

Hit Papers

Polyethylene glycol (PEG): The nature, immunogenicity, an... 2022 2026 2023 2024 2022 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Polyethylene glycol (PEG): The nature, immunogenicity, and role in the hypersensitivity of PEGylated products
    2022 286 citations Mohamed Yousif Ibrahim, Eslam Ramadan et al. Journal of Controlled Release profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nehal E. Elsadek Egypt 10 297 201 125 93 70 17 614
Sherif E. Emam Egypt 14 443 1.5× 207 1.0× 147 1.2× 105 1.1× 157 2.2× 28 828
Pierre‐Alain Burnouf Taiwan 12 456 1.5× 221 1.1× 173 1.4× 85 0.9× 94 1.3× 15 738
Emanuela Gentile United States 8 283 1.0× 229 1.1× 262 2.1× 54 0.6× 78 1.1× 12 670
Keita Un Japan 13 309 1.0× 229 1.1× 270 2.2× 90 1.0× 40 0.6× 22 625
Gholamreza Tavoosidana Iran 13 428 1.4× 115 0.6× 130 1.0× 63 0.7× 138 2.0× 43 758
Yihua Pei China 19 452 1.5× 134 0.7× 155 1.2× 115 1.2× 157 2.2× 30 783
Min Woo Kim South Korea 14 407 1.4× 272 1.4× 306 2.4× 52 0.6× 97 1.4× 57 778
Roun Heo South Korea 11 282 0.9× 226 1.1× 181 1.4× 98 1.1× 42 0.6× 14 637

Countries citing papers authored by Nehal E. Elsadek

Since Specialization
Citations

This map shows the geographic impact of Nehal E. Elsadek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nehal E. Elsadek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nehal E. Elsadek more than expected).

Fields of papers citing papers by Nehal E. Elsadek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nehal E. Elsadek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nehal E. Elsadek. The network helps show where Nehal E. Elsadek may publish in the future.

Co-authorship network of co-authors of Nehal E. Elsadek

This figure shows the co-authorship network connecting the top 25 collaborators of Nehal E. Elsadek. A scholar is included among the top collaborators of Nehal E. Elsadek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nehal E. Elsadek. Nehal E. Elsadek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Shimizu, Taro, Nehal E. Elsadek, Sherif E. Emam, et al.. (2023). Anti-PEG IgM production induced by PEGylated liposomes as a function of administration route. Journal of Controlled Release. 360. 285–292. 22 indexed citations
3.
Emam, Sherif E., Nehal E. Elsadek, Taro Shimizu, & Tatsuhiro Ishida. (2023). The Post-insertion Method for the Preparation of PEGylated Liposomes. Methods in molecular biology. 2622. 159–172. 7 indexed citations
4.
Shimizu, Taro, Amr S. Abu Lila, Nehal E. Elsadek, et al.. (2022). A mouse model for studying the effect of blood anti-PEG IgMs levels on the in vivo fate of PEGylated liposomes. International Journal of Pharmaceutics. 615. 121539–121539. 12 indexed citations
5.
Ibrahim, Mohamed Yousif, Eslam Ramadan, Nehal E. Elsadek, et al.. (2022). Polyethylene glycol (PEG): The nature, immunogenicity, and role in the hypersensitivity of PEGylated products. Journal of Controlled Release. 351. 215–230. 286 indexed citations breakdown →
6.
Elsadek, Nehal E., Tarek Ibrahim, Hitesh Chopra, et al.. (2022). Electrospun Nanofibers Revisited: An Update on the Emerging Applications in Nanomedicine. Materials. 15(5). 1934–1934. 33 indexed citations
7.
Elsadek, Nehal E., et al.. (2022). The Impact of the Regional Ring Road on Urban Development (Case Study of Greater Cairo Region). 40(1). 20–30. 1 indexed citations
8.
9.
10.
Emam, Sherif E., Nehal E. Elsadek, Amr S. Abu Lila, et al.. (2021). Anti-PEG IgM production and accelerated blood clearance phenomenon after the administration of PEGylated exosomes in mice. Journal of Controlled Release. 334. 327–334. 58 indexed citations
11.
Elsadek, Nehal E., Sherif E. Emam, Hidenori Ando, et al.. (2021). Using Bio-Layer Interferometry to Evaluate Anti-PEG Antibody-Mediated Complement Activation. Biological and Pharmaceutical Bulletin. 45(1). 129–135. 2 indexed citations
12.
Shimizu, Taro, Nehal E. Elsadek, Sherif E. Emam, et al.. (2021). Incorporating Gangliosides into PEGylated Cationic Liposomes that Complexed DNA Attenuates Anti-PEG Antibody Production but Not Anti-DNA Antibody Production in Mice. Molecular Pharmaceutics. 18(6). 2406–2415. 8 indexed citations
13.
Elsadek, Nehal E., Amr S. Abu Lila, Sherif E. Emam, et al.. (2020). Pegfilgrastim (PEG-G-CSF) induces anti-PEG IgM in a dose dependent manner and causes the accelerated blood clearance (ABC) phenomenon upon repeated administration in mice. European Journal of Pharmaceutics and Biopharmaceutics. 152. 56–62. 31 indexed citations
14.
15.
Elsadek, Nehal E., Sherif E. Emam, Amr S. Abu Lila, et al.. (2020). Pegfilgrastim (PEG-G-CSF) Induces Anti-polyethylene Glycol (PEG) IgM <i>via</i> a T Cell-Dependent Mechanism. Biological and Pharmaceutical Bulletin. 43(9). 1393–1397. 11 indexed citations
16.
Elsadek, Nehal E., Taro Shimizu, Amr S. Abu Lila, et al.. (2020). Impact of Pre-Existing or Induced Anti-PEG IgM on the Pharmacokinetics of Peginterferon Alfa-2a (Pegasys) in Mice. Molecular Pharmaceutics. 17(8). 2964–2970. 20 indexed citations
17.
Emam, Sherif E., Amr S. Abu Lila, Nehal E. Elsadek, et al.. (2019). Cancer cell-type tropism is one of crucial determinants for the efficient systemic delivery of cancer cell-derived exosomes to tumor tissues. European Journal of Pharmaceutics and Biopharmaceutics. 145. 27–34. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sherif E. Emam Breakdown of academic impact, for papers by Pierre‐Alain Burnouf Breakdown of academic impact, for papers by Emanuela Gentile Breakdown of academic impact, for papers by Keita Un Breakdown of academic impact, for papers by Gholamreza Tavoosidana Breakdown of academic impact, for papers by Yihua Pei Breakdown of academic impact, for papers by Min Woo Kim Breakdown of academic impact, for papers by Roun Heo
Rankless by CCL
2026